Are you searching for medications to treat 'Peripheral Neuropathy'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Peripheral Neuropathy.
Peripheral neuropathy can cause severe disability and increases the risk of limb amputation, which significantly diminishes quality of life, but currently there is no approved treatment.
Neuropathic pain associated with diabetic peripheral neuropathy (DPN ... good efficacy with a tolerable side-effect profile in the treatment of PDN. According to the Australian datasheet, 1438 ...
In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...
The drug is not metabolized ... somnolence and peripheral edema. From this data, pregabalin can be considered effective and safe for the treatment of PDN. The main adverse effects observed in ...
Considering taking supplements to treat peripheral neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of peripheral neuropathy. Follow the links to read ...
The go-to answers are drugs, surgeries, and injections but ... to understand which form of this condition you suffer from (e.g. peripheral neuropathy, mononeuropathy, autonomic neuropathy, etc.) and ...
Researchers found that neuromuscular training significantly reduces the incidence and severity of chemotherapy-induced peripheral neuropathy, improving patient quality of life and treatment outcomes.
The go-to answers are drugs, surgeries, and injections but ... to understand which form of this condition you suffer from (e.g. peripheral neuropathy, mononeuropathy, autonomic neuropathy, etc.) and ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...
manufacture and commercialise the drug candidate “SON-080” for the treatment of diabetic peripheral neuropathy in India. According to a press statement, “SON-080” is Sonnet’s proprietary ...
Alkem Labs enters into licensing agreement with Sonnet BioTherapeutics for its diabetic peripheral neuropathy drug in India Sage said it will continue to test dalzanemdor as a treatment for ...